SVYAX | VMVAX | SVYAX / VMVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 16 years | 13 years | - |
Gain YTD | 4.476 | 1.921 | 233% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 3000 | 3,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 729M | 30.9B | 2% |
Annual Yield % from dividends | 2.21 | 2.14 | 104% |
Returns for 1 year | 6.60 | 12.44 | 53% |
Returns for 3 years | -4.71 | 15.34 | -31% |
Returns for 5 years | -9.25 | 38.46 | -24% |
Returns for 10 years | -0.97 | 81.26 | -1% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HERVX | 10.41 | -0.01 | -0.10% |
Hartford Emerging Markets Equity R6 | |||
RYCFX | 43.39 | -0.15 | -0.34% |
Rydex Biotechnology C | |||
EPLMX | 21.91 | -0.18 | -0.81% |
NYLI Epoch U.S. Equity Yield SIMPLE Cl | |||
CMLEX | 57.35 | -0.62 | -1.07% |
American Funds American Mutual 529E | |||
GCTIX | 48.22 | -1.05 | -2.13% |
Goldman Sachs US Tax-Managed Eq Instl |